Lecozotan
Lecozotan (developmental code name SRA-333) is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. , the first Phase III clinical trial has been completed.
≈ 1 min read
Lecozotan. encyclopegia.org, snapshot enwiki-001359092371. /a/lecozotan
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Lecozotan (developmental code name SRA-333) is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. , the first Phase III clinical trial has been completed.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1359092371 under CC BY-SA 4.0; modifications have been made.